Here's a look at what viewers found most interesting during the month of October on dicardiology.com

As another month comes to a close, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com during the month of October. 

1. Joint Statement on Aortic Valve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons

November 6, 2023 — Advances in artificial intelligence have enabled the development and application of AI tools that may be effective at detecting heart valvular disease and predicting the risk of cardiovascular disease events, according to preliminary research in two studies to be presented at the American Heart Association’s 

November 6, 2023 — Atrial fibrillation (AF) diagnosis was associated with a 45% increased risk of mild cognitive impairment (MCI) among a cohort of 4.3 million individuals in the UK, according to a new study published in JACC: Advances. These findings suggest that cardiovascular risk factors and multiple comorbidities could further the progression from MCI to dementia in this cohort. 

November 3, 2023 — In the U.S., someone has a stroke every 40 seconds and dies from it every three minutes and 14 seconds, according to the Centers for Disease Control and Prevention. When it comes to stroke, experts echo the fact that time is brain. Faster treatment translates to better outcomes, and certain treatments, like the clot-busting drug tPA, have a strict time window for administration. 

November 3, 2023 — The American Heart Association will present its 2023 Research Achievement Award to Marlene Rabinovitch, M.D., of Stanford University. The Research Achievement Award will be recognized during the Presidential Session on Sunday, Nov.

November 3, 2023 — The national Board of Directors of the American Heart Association last week voted to provide full support to the House of Cardiology’s consortium proposal to create a new American Board of Cardiovascular Medicine (ABCVM) specifically to certify cardiovascular physicians.

In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and cause cell death. Radiofrequency ablation (RFA) treatment uses energy to heat the tissue until it dies, resulting in its inability to transmit electrical signals that trigger arrhythmias. Cryoballoon ablation (CBA) uses a super-cooled balloon at the end of a catheter to freeze the tissue for the same result. Thermal methods for ablation have been successfully used for years; however, these methods carry uncommon yet serious risks.

The Latest Developments in Cardiac Ablation

November 2, 2023 — The latest STRIKE-PE data, presented by Penumbra, Inc. at the Vascular Interventional Advances Conference, VIVA23, showed that computer assisted vacuum thrombectomy (CAVT) for the treatment of pulmonary embolism is safe and effective at reducing right heart strain, and also improved clinical and functional outcomes.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now